Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:53 PM
Ignite Modification Date:
2025-12-24 @ 11:53 PM
NCT ID:
NCT04541251
Eligibility Criteria:
Inclusion criteria:
* The patients have stage IB-IIIA NSCLC.
* Patient ages are ≥ 18 years old, regardless of gender.
* The patients have an ECOG ps of 0-1, with a condition suitable for surgery.
* The patients have not received any anti-tumor treatment.
* The patients have adequate blood function.
* The patients have adequate organ function.
* The patients had been using an appropriate method of contraception, and there exists a negative pregnancy test (serum or urine) for women.
* The patients will give their signed informed consent.
Exclusion criteria:
* Patients who had a prior allogeneic tissue or organ transplantation.
* Patients who have multiple cancers.
* Patients who have any severe or uncontrolled systemic diseases.
* Patients with a positive test for HIV, HBV, or HCV.
* Patients with severe infection or with an infection that required antibiotic therapy.
* Patients with a history of interstitial lung disease, active tuberculosis, or autoimmune disease.
* Patients who have participated in any other clinical trials.
* Patients who are considered ineligible by the investigator.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04541251
Study Brief:
Protocol Section:
NCT04541251